Different inbred and congenic resistant strains of mice were immunized with staphylococcal exfoliative toxin A (ETA). In antibody responses measured in sera of mice by a passive hemagglutination technique, A/J, DBA/2, BALB/c, B1OA, B1OD2, BIOS, and A.SW were high responders. C57BL/10 (BlO), A.BY, and DBA/1 were low responders. The congenic C3H/HeJ and C3H.SW mice were, respectively, high and low responders. The observation that the immune responses of the mice to ETA were closely linked with the haplotypes of their H-2 complexes suggests the existence of an H-2-linked immune response (Ir) gene coding for the production of humoral antibodies to ETA. Four B1OA recombinants were used to map this gene within the H-2 complex. The finding that B1OA(2R) and BlOA(4R) were high responders, whereas B1OA(3R) and BlOA(5R) were low responders, indicates that the gene controlling antibody response to ETA is located in the I-A subregion or the H-2K end within the H-2 complex. We wish to propose the name Ir-ETA for this gene. The function of Ir-ETA seems to be at least related to antigen recognition at the T-lymphocyte level. Neonatal mice are generally susceptible to ETA regardless of their H-2 haplotypes. However, the neonatal mice born to a high-responder mother immunized with ETA were resistant to the subcutaneous challenge of ETA, but those born to an immunized low-responder mother were susceptible to the challenge. This result suggests that if the mother is a high responder to ETA and is effectively immunized with ETA, the maternal immunity makes it possible to neutralize this toxin in neonatal mice.
Staphylococcal exfoliative toxin (ET) is an extracellular product of Staphylococcus aureus isolated from patients with staphylococcal scalded skin syndrome (SSSS) (3, 12, 15, 23, 32) . As the ET has a splitting effect at the granular layer of skin in humans and mice, it has been regarded as the causative agent of SSSS in humans (10, 20) . Two types of ET, ETA and ETB, differing in serological and physicochemical properties, were reported by Kondo et al. (16) (17) (18) . The ETA is a polypeptide toxin lacking cysteine, with a molecular weight of 24 ,000. It is stable at 100°C for 20 min, and at -30°C, it is stable for more than 1 year (16) . The ETA is more susceptible than ETB is to treatment with EDTA, and the ETA contains 1 g of copper atoms per mol of toxin (14, 28) .
Rabbits were not susceptible to the toxin but could produce specific antibodies to the ETA and ETB. Neonatal mice were one of the susceptible animals other than humans (9, 13) , but a conventional outbred mouse strain (ICR) or an inbred hairless mouse strain (HRS/J) was generally unable to produce high levels of antibody to the toxin. However, when some inbred and congenic resistant strains with the defined major histocompatibility complex (H-2 complex) were immunized with ETA, they could be classified into high-and low-responder groups.
From these observations, we were interested in the identification and characterization of the immune response genes which determine the response to ETA in mice. Here, we report on the immune response to ETA in various inbred, congenic, and recombinant mouse strains, the heredity anal-ysis of the immune response gene, the analysis of Tlymphocyte proliferation in response to ETA in high-and low-responder mice, and the susceptibilities to ETA in neonatal mice born to high-and low-responder mothers immunized with ETA or not immunized.
MATERIALS AND METHODS
Mice. Adult male and female mice, 4 immunodiffusion method by using a corresponding rabbit antibody against ETA (18) .
Immunization. Mice were immunized at 2-week intervals with three subcutaneous injections of 60 ,ug of ETA in 0.1 ml of saline emulsified with an equal volume of Freund incomplete adjuvant (Difco Laboratories). These mice were boosted with 20 ,ug of ETA 2 weeks later; 10 days later, they were bled under ether by cardiac puncture. Four or five mice were used in each group in these experiments.
Assay of antibody to ETA. (25 RI) were made in a microtiter tray, and 25 ,u of 1% ETA-coupled SRBC was added to each diluent. The trays were vibrated for 5 min, incubated at 37°C for 3 h, and then left overnight at 4°C before being read. The agglutination titer in each serum sample was expressed as 2n+2, n being the number of wells which showed the agglutination of ETA-coupled SRBC in twofold dilutions from a 1:8 dilution of sera. If 1:8 dilutions of sera showed no agglutination of ETA-coupled SRBC, n was estimated to be 0. The mean of n with four or five mice in a group was expressed as the titer of antibody to ETA for each group + the standard deviation. The immunodiffusion procedure in this study was also done by a previously described method (16, 18) .
Analysis of T-lymphocyte proliferation to ETA. Spleens of mice were collected and placed in cold Hanks balanced salt solution supplemented with 100 U of penicillin per ml, 100 ,g of streptomycin per ml, and 2.5% fetal bovine serum (GIBCO Laboratories, Grand Island, N.Y.). Cell suspensions were prepared by gently teasing the spleens by using a tissue grinder; the cell suspensions were transferred to tubes and allowed to stand for a few minutes to permit large clumps of cells and debris to settle. The cell suspensions were collected, centrifuged, suspended in ammonium chloride buffer to lyse the erythrocytes, washed twice with Hanks balanced salt solution, and suspended in TC199 (GIBCO) supplemented with antibiotics and serum as described above and 3 x 10-5 M 2-mercaptoethanol (Sigma Chemical Co., St. Louis, Mo.). The T-cell populations were enriched by passing the cell suspensions through a nylon wool column (11) . The contamination of the passed cell suspension with B cells was determined by using a fluorescein-conjugated rabbit anti-mouse-immunoglobulin G serum (Cooper Biomedical, Inc., West Chester, Pa.). Less than 1% of the cells in the purified population were immunoglobulin positive, in contrast to 25 to 30% immunoglobulin G-positive cells present in unfractionated cell suspension. The cells were counted and adjusted to 106 live cells per ml of TC199 supplemented with antibiotics and serum as above. Samples (100 RI) of this suspension were placed in the plastic microculture plate wells (no. 3034; Becton Dickinson Labware, Oxnard, Calif.). Samples (100 ,ul) of ETA solution (0, 10, 100, or 1,000 ,ug of ETA per ml) were added to each well. After 3 days of culture at 37°C in a humidified atmosphere of 5% CO2 in air, 10 ,ul of stock solution (100 ,uCi/ml) of [3H]thymidine (New England Nuclear Corp., Boston, Mass.) was added to each well. After 20 h, the cells were harvested onto filter disks by using a cell harvester (Labo Mash; Labo Science Co., Ltd., Tokyo, Japan). The filter paper disks were dried and placed in scintillation vials containing 2 ml of PPO-POPOP [2,5- 
RESULTS
Antibody responses to ETA in mice. Sera from a variety of inbred and congenic mouse strains which were immunized with ETA were assayed by the PHA test for antibody to ETA. The results for the sera from different strains are summarized in Table 1 . The strains could be divided into two groups: high-responder strains and low-responder strains. Strains A/J, B1OA, DBA/2, B1OD2, BALB/c, C3H/HeJ, B1OS, and A.SW belong to the high-responder group. Strains B10, A.BY, C3H.SW, and DBA/1 belong to the lowresponder group. It should be noted that the two groups of congenic resistant mouse strains (B10, B1OA, B1OD2, and B1OS) and (C3H/HeJ and C3H.SW), which differ only at the H-2 complex within each group, also differ in their antibody response potentials to ETA. This indicates that the immune response to ETA in the mouse strains is associated with the immune response genes in the H-2 complexes. The immune response region associated with the H-2 complex in mice can be divided into five different subregions: I-A, I-B, I-J, I-E, and I-C (30 b Antibody levels to ETA are expressed as 2 +2 as described in Table 1 , footnote b. Each value is the mean ± the standard deviation of n in 2"+ 2 s in these regions had high antibody response potentials to ETA, whereas those with genotype b and q in these regions were low responders to ETA (Table 2) . Heredity analysis of the antibody responses to ETA. To ascertain a linkage between the H-2 complex and the antibody response potentials to ETA, we made crosses and backcrosses between B1OD2 (a high-responder strain) and B10 (a low-responder strain). These mice were immunized with ETA by the standard procedure. Antibody levels to ETA in the sera were assayed by the PHA test. The discrimination between high and low antibody titers for the purposes of determining the segregation of the phenotype relied on a break between mice giving titers in which n ' 5 in the 2n+2 for high responders and those giving n _ 4 for low responders, because the agglutination titers of B10 mice have usually been below n = 4 in the 2n1+2. The patterns of inheritance of antibody responses to ETA in crosses and backcrosses between B10 and B1OD2 are summarized in Table 3 . The 32 (BlO x B1OD2)F1 mice were high responders. In the heterozygotes at the H-2 complex, high antibody response potentials to ETA were associated with a dominant gene (H1-2d) and the H-2b gene seemed to be recessive. The 54 [(B10 x BlOD2)Fl x (BlO x B10D2)F1]F2 mice were segregated in a nearly 3.5:1 ratio between the high-responder group and the low-responder group. Moreover, the 57 [(B10 x BlOD2)N1 x B10]N2 mice were segregated in a nearly 1.3:1 ratio between the high-responder group and the lowresponder group. The seven F2 and four N2 mice in these groups were medium responders (5 n n-' 6 in the 2"1+2) and were included in the high-responder groups, because these mice had acquired parts of the high-responder gene to ETA. It made sense to increase the number of mice in the (Table 4 ). The B1OA, B1OA(2R), and B1OA(4R) strains were high responders, and the B1OA(3R), B1OA(5R), and B10 strains were low responders. As already shown in Table 2 , genotypes k and d were high responders. When genotype d or k was present in the I-J, I-E, or I-C region, mice did not show any high levels of antibody production in their sera [B1OA(3R) and B1OA(5R)]. On the other hand, the recombinant strain of mice with genotype k in the I-A region and genotype b in other regions [B1OA(4R)] showed production of antibody to ETA in their sera. Therefore, the I-A region or H-2K end in the H-2 complex was functioning as an immune response gene controlling the production of antibody to ETA.
Proliferative responses of splenic T cells for ETA. The ETA-primed splenic T cells from B1OD2 and B10 mice were cultured at 105 cells in flat-bottom microculture plates for 4 days with 1, 10, or 100 ,ug of ETA. The proliferative responses of splenic T cells from B10D2 (a high responder) could be detected by using 100 ,ug of ETA (Fig. 1) , whereas splenic T cells from B10 (a low responder) did not show any proliferative responses at the dose of ETA indicated in Fig.  1 . It is unclear whether ETA-primed splenic T cells from B10 recognized the antigen or not, since the amounts of ETA in this experiment were below 100 ,ug per well. The nonprimed splenic T cells from both B1OD2 and B10 mice did not show any proliferative response to ETA under the same doses shown in Fig. 1 (data not shown) . These results show that the high immune responses to ETA in mice having highresponder phenotypes within the I-A subregion were related to the amount of T lymphocytes that recognized ETA antigen.
Susceptibilities to ETA of neonatal mice born to high-or low-responder mothers. To determine whether susceptibilities of neonatal mice to ETA were related to the H-2 complexes, neonatal mice born to high-(B1OD2) or low-(B110) responder mothers without immunizations were subcutaneously inoculated with 0.8, 1.6, and 2.4 ,ug of ETA. Neonatal mice born to either low-or high-responder mothers were equally sensitive to these amounts of ETA (Table 5 ).
a For the immunization schedule, see Table 1 , footnote a. b Both possible sex combinations were used. ' Antibody levels to ETA in sera were measured by the PHA test and are expressed as 2 n2 as described in Table 1, 
a Five mice of each recombinanit were immunized with ETA. For immunization, see Table 1 , footnote a.
b Antibody levels to ETA are expressed as 2n+2 as described in Table 1 , footnote b. Each value is the mean ± the standard deviation of n in 21+2. autosomal dominant gene in the H-2 complex of B1OD2 controlled the production of antibody to ETA. In various B1OA recombinant mice, B1OA(2R) and B1OA(4R) were high responders to ETA. Antibody production occurred when genotype k existed at the I-A subregion (B1OA.4R) and not at the I-J and I-E subregions (B1OA.3R and B1OA.5R). Furthermore, B1OA(5R) mice, which have high-responder markers between the I-J and the H-2D end, showed low responses to ETA. This indicates that a high-responder gene to ETA existed in the I-A subregion or in the H-2K end within the H-2 complex.
In many studies on native protein antigens, staphylococcal nuclease (Nase) (21), lactate dehydrogenase (22) , insulin (29) , thyroglobulin (1, 31), sperm whale myoglobin (4, 24) , and hemoglobin (19) are controlled by immune response genes related in their antibody productivities to the H-2 complexes of mice. It is of interest that the H-2 haplotypes showed nearly the same high and low response to both ETA and Nase. However, the immune response gene to ETA (Ir-ETA) existed in the I-A region, but the Ir-Nase gene was in the I-B region. It is clear that various peptide fragments in native protein antigens like Nase or sperm whale myoglobin are controlled in their antibody productions by different immune response genes (6, 7, 25, 27) , It makes sense that humoral immune responses in animals come from aggregations of each response to a fragment, and a variety of small immune reactions are made from the variety of epitopes in fragments on native peptide antigens. The epitopes in ETA which correspond to the immune response genes may be different from those of Nase. An analysis of the amino acid sequence of ETA is in progress. Although the possibility of the complementation phenomenon reported by Dorf and The function of the Jr-ETA gene in our experiments is at present the subject of much speculation. It is well known that the immune response to antigens in an animal consists chiefly of macrophage functions; cellular interactions among macrophages, T lymphocytes, and B lymphocytes; and the existence of molecules active in enhancing and suppressing inmmune responses. However, the finding that antigenprimed splenic T lymphocytes from high responders (B1OD2) showed a proliferative response when incubated with 100 p.g of ETA and those from low responders (B10) showed less response suggests that the Ir-ETA gene is related to antigen recognition at the level of the T lymphocytes (2) .
The susceptibility to ETA in neonatal mice was not related to their H-2 complexes. The granular layer in the shin of neonatal mice was the target of ET (10, 20) , and even 0.38 ig of ETA had a shin-splitting activity (14) . Gangliosides are thought to be receptors of ET (14) , and mouse species may have some receptors of ET. Neonatal mice born to highresponder mothers immunized with ETA showed resistance to 2.4 p.g of ETA and not to 8 jig of ETA. Although it was not confirmed whether antibody to ETA exists in the granular layers, antibody to ETA which enters into neonatal mice through the placenta, of mothers immunized with ETA may neutralize ETA in neonatal mice. Resistance to SSSS in mice seems to be complicated and to be related to the existence of antibody to the toxins. If high-responder strains do not have the antibody to ET, they seem to be sensitive to the disease.
Staphylococcal ETB is also an extracellular product of S. aureus isolated from patients with SSSS (16, 18, 26) . Our findings are from experiments with ETA, and the ETB may change the results of these experiments. Search for the Ir-ETB gene could be the next investigation.
